Outcomes of rituximab for EBV viremia/post-transplant lymphoproliferative disease in CD34+ selected allogeneic hematopoietic stem cell transplantation Meeting Abstract

Fulltext large  

Authors: Poppiti, K.; Lin, A.; Adel, N. G.; Hilden, P.; Castro-Malaspina, H.
Abstract Title: Outcomes of rituximab for EBV viremia/post-transplant lymphoproliferative disease in CD34+ selected allogeneic hematopoietic stem cell transplantation
Meeting Title: 58th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 128
Issue: 22
Meeting Dates: 2016 Dec 3-6
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2016-12-02
Language: English
ACCESSION: WOS:000394452506186
PROVIDER: wos
Notes: Meeting Abstract: 4623 -- Source: Wos
MSK Authors
  1. Hugo Castro-Malaspina
    230 Castro-Malaspina
  2. Nelly G Adel
    41 Adel
  3. Patrick Dale Hilden
    79 Hilden
  4. Andrew Pei-En Lin
    14 Lin
  5. Kristen Marie Poppiti
    2 Poppiti
Related MSK Work